WHO ICTRP trial
Effect of drug intervention on postpartum depression
ChiCTR-ROC-17013357 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-ROC-17013357 |
|---|---|
| Public title | Effect of drug intervention on postpartum depression |
| Scientific title | Effect of dexmedetomidine on maternal intervention in cesarean section for postpartum depression |
| Primary sponsor | the Anesthesia Department of the Third Xiangya Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | Other |
| Countries | China |
| Conditions | postpartum depression |
| Interventions | dexmedetomidine group:After delivery, participants received 0.5ug/kg intravenous dexmedetomidine (Infusion speed was 0.375ml/kg.h and infusion time was 20min).The PCIA protocol was 150ug sufentanil + 150ug dexmedetomidinea+0.25mg… |
| Registration date | Nov 13, 2017 |
| Target size | dexmedetomidine group:300;control group:300 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: